BULLFROG AI HOLDINGS INC. - COMMON STOCK

BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

26 8月 2024 07:00:00 条件 Nasdaq GlobeNewswire

BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug Targets

25 7月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on June 12

29 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire

BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders

16 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire

BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo

09 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire

BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute

08 3月 2024 07:00:00 条件 Nasdaq GlobeNewswire

BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer

26 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire

BullFrog AI Announces Underwriter’s Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company’s Common Stock

21 2月 2024 11:01:05 条件 Nasdaq GlobeNewswire

BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip

09 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire

BullFrog AI Announces Closing of $5.7 Million Public Offering

05 2月 2024 09:00:57 条件 Nasdaq GlobeNewswire

Bullfrog AI Announces Pricing of $5.7 Million Public Offering

01 2月 2024 08:00:00 条件 Nasdaq GlobeNewswire

BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala

26 1月 2024 06:30:00 条件 Nasdaq GlobeNewswire

BullFrog AI’s Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data

17 1月 2024 06:00:00 条件 Nasdaq GlobeNewswire

BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer

16 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire

BullFrog AI to Present at Webull LIVE! Healthcare Webinar on January 17

11 1月 2024 15:05:00 条件 Nasdaq GlobeNewswire

BullFrog AI Issues Letter to Shareholders

29 12月 2023 07:00:00 条件 Nasdaq GlobeNewswire

BullFrog AI Launches Preclinical Study to Investigate BF-114’s Potential in Battling Obesity

06 12月 2023 06:00:00 条件 Nasdaq GlobeNewswire

BullFrog AI to Present at Benzinga All Access Event on October 20

18 10月 2023 08:00:00 条件 Nasdaq GlobeNewswire

BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform

05 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire

BullFrog AI Announces Positive Data from Preclinical Study Evaluating Novel Prodrug of Mebendazole for Treatment of Glioblastoma

26 9月 2023 07:00:01 条件 Nasdaq GlobeNewswire